Copyright
©2014 Baishideng Publishing Group Co.
World J Orthop. Apr 18, 2014; 5(2): 151-157
Published online Apr 18, 2014. doi: 10.5312/wjo.v5.i2.151
Published online Apr 18, 2014. doi: 10.5312/wjo.v5.i2.151
Patient number | Age,yr | Sex | Organism | Category | CRP (Init-ial/final) | Surgical intervention | Number of surg-ical procedures | Linezolid duration (d) | Concurrent antibiotics | Previous antibiotics prior to linezolid | Follow-up (mo) | Resolution |
1 | 43 | M | MRSA | Post Trauma | 301/< 5 | Yes | 2 | 14 | Rifampicin | Vancomycin | 57 | Yes |
2 | 47 | F | MRSA | Non Trauma | 148/9.8 | Yes | 2 | 28 | No | Vancomycin | 3 | Yes |
Clarithromycin | ||||||||||||
3 | 43 | M | MRSA | Non Trauma | 235/9.8 | No | 0 | 84 | No | N | 14 | Yes |
4 | 80 | F | Coag neg staph | Arthroplasty | 30/< 5 | Yes | 2 | 28 | No | Vancomycin | 33 | Yes |
5 | 81 | F | Coag Neg staph | Arthroplasty | 134/39 | Yes | 1 | 42 | Rifampicin | Vancomycin | 25 | Yes |
6 | 20 | M | MRSA | Post Trauma | 146/< 5 | Yes | 5 | 28 | No | Flucloxacillin | 23 | Yes |
Vancomycin | ||||||||||||
Rifampicin | ||||||||||||
7 | 52 | F | Staph aureus | Arthroplasty | 133/54 | Yes | 3 | 28 | No | Vancomycin | 41 | Yes |
Pseudomonas | Clindamycin | |||||||||||
8 | 79 | M | Staph epidermidis | Arthroplasty | 153/15.5 | Yes | 2 | 28 | Rifampicin | Vancomycin | 20 | Yes |
Coag Neg staph | ||||||||||||
Coliforms | ||||||||||||
9 | 73 | F | Coag Neg staph | Arthroplasty | 106/46 | Yes | 2 | 28 | No | Vancomycin | 24 | Yes |
Rifampicin | ||||||||||||
10 | 45 | M | None identified | Post Trauma | 129/< 5 | Yes | 2 | 28 | No | Vancomycin | 36 | Yes |
11 | 48 | M | Coag Neg staph | Arthroplasty | 79/15 | Yes | 6 | 28 | No | Vancomycin | 41 | Yes |
Strep viridians | ||||||||||||
Coliforms | ||||||||||||
Acro Xylo | ||||||||||||
12 | 43 | M | MRSA | Post Trauma | 72/< 5 | Yes | 1 | 28 | No | None | 24 | Yes |
13 | 63 | F | Staph aureus | Post Trauma | Sep-63 | Yes | 1 | 70 | No | Vancomycin | 6 | Yes |
14 | 47 | M | MRSA | Post Trauma | 124/12 | Yes | 4 | 42 | No | Vancomycin | 19 | No |
15 | 64 | F | Staph aureus | Non Trauma | 155/5.5 | No | 0 | 8 | No | Vancomycin | RIP | No |
E. coli | ||||||||||||
Enterococcus | ||||||||||||
16 | 83 | F | Enterococcus | Arthroplasty | 21/18.6 | Yes | 1 | 21 | No | Vancomycin | 39 | No |
17 | 73 | M | Coag neg staph | Arthroplasty | 68/< 5 | Yes | 1 | 28 | No | Vancomycin | 50 | Yes |
18 | 68 | M | MRSA | Post Trauma | 91/< 5 | Yes | 1 | 28 | No | Vancomycin | 18 | Yes |
Group B strep | ||||||||||||
19 | 77 | M | MRSA | Arthroplasty | 65/62 | Yes | 4 | 28 | No | Vancomycin | 47 | No |
Coliforms | ||||||||||||
Gram negative bacillus | ||||||||||||
20 | 86 | M | MRSA | Non Trauma | 155/26 | Yes | 2 | 10 | No | Vancomycin | 6 | Yes |
Rifampicin | ||||||||||||
21 | 79 | M | Coag Neg staph | Arthroplasty | 29/5 | Yes | 3 | 42 | No | Vancomycin | 22 | No |
Rifampicin | ||||||||||||
22 | 35 | M | Coag Neg staph | Post Trauma | 64/< 5 | Yes | 3 | 42 | No | Vancomycin | 45 | Yes |
- Citation: Joel J, Graham SM, Peckham-Cooper A, Korres N, Tsouchnica H, Tsiridis E. Clinical results of linezolid in arthroplasty and trauma MRSA related infections. World J Orthop 2014; 5(2): 151-157
- URL: https://www.wjgnet.com/2218-5836/full/v5/i2/151.htm
- DOI: https://dx.doi.org/10.5312/wjo.v5.i2.151